From the clip:
“We are excited to test sozinibercept in large P3 programmes […] with the goal of […] showing that we can improve visual acuity hopefully by up to 5 letters or more.“
To my memory, this is the first time somebody sharing responsibility for running the trials dares to explicitly mention a „5 letters or more“ improvement as what OPT internally is really hoping for. If this hope materializes then Eichenbaum is absolutely right saying that sozinibercept would disrupt the wAMD market.
I just cannot believe existing players continuing to stay quiet with this disruptive opportunity being up for sale / partnership just 15 months ahead of P3 results. Therefore, I’d indeed expect a partnership occurring over the next 3 months being more probable than a classic CR.
- Forums
- ASX - By Stock
- Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
From the clip:“We are excited to test sozinibercept in large P3...
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
64.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $424.1M |
Open | High | Low | Value | Volume |
63.0¢ | 64.0¢ | 62.0¢ | $54.33K | 86.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 36038 | 62.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
64.0¢ | 8970 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 36038 | 0.620 |
6 | 32113 | 0.610 |
3 | 80163 | 0.605 |
10 | 55268 | 0.600 |
1 | 40000 | 0.595 |
Price($) | Vol. | No. |
---|---|---|
0.640 | 8970 | 1 |
0.650 | 3700 | 3 |
0.655 | 4999 | 1 |
0.660 | 32125 | 2 |
0.665 | 10000 | 1 |
Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
62.8¢ |
  |
Change
0.000 ( 1.18 %) |
|||
Open | High | Low | Volume | ||
62.5¢ | 63.0¢ | 62.0¢ | 15047 | ||
Last updated 15.59pm 24/05/2024 ? |
Featured News
OPT (ASX) Chart |